RECRUITING

Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

Talk to us

Conditions

Anesthesia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A comparison of two anesthetic techniques for total knee replacements: (1) Peri-Articular Injection (PAI), local infiltration between the popliteal artery and capsule of the knee block (IPACK) and single-shot adductor canal block (ACB) vs. (2) PAI, IPACK and continuous adductor canal block catheter (ACC).

Official Title

Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS)- Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blind Controlled Trial

Quick Facts

Study Start:2018-11-16
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03747146

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
  2. * Planned use of regional anesthesia
  3. * Ability to follow study protocol
  4. * English speaking (secondary outcomes include questionnaires validated in English only)
  5. * Lives within one hour of the hospital
  6. * Has a smart phone
  1. * Hepatic or renal insufficiency
  2. * Younger than 18 years old or older than 65 years ol
  3. * Patients undergoing general anesthesia
  4. * Allergy or intolerance to one of the study medications
  5. * BMI \>40
  6. * Diabetes
  7. * American Society of Anesthesiologists (ASA) status III or IV
  8. * Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
  9. * Patients with chronic pain (from a referral to chronic pain service) or a pain catastrophizing scale (PCS \>30)
  10. * Patients with severe valgus deformity or flexion contracture
  11. * Patients unable to follow home catheter instructions and unwilling to go home with an infusing catheter
  12. * Patients who have no home caregivers in the event that a catheter is to be sent home with the patient
  13. * Patients with planned stay at rehab facility (to avoid medical device being tampered with at the rehab facility)
  14. * Non-English speakers (secondary outcomes include questionnaires validated in English only)

Contacts and Locations

Study Contact

George Birch, BS
CONTACT
212-774-7377
birchg@hss.edu

Principal Investigator

David Kim, MD
PRINCIPAL_INVESTIGATOR
Hospital for Special Surgery, New York

Study Locations (Sites)

Hospital for Special Surgery
New York, New York, 10023
United States

Collaborators and Investigators

Sponsor: Hospital for Special Surgery, New York

  • David Kim, MD, PRINCIPAL_INVESTIGATOR, Hospital for Special Surgery, New York

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-11-16
Study Completion Date2025-12

Study Record Updates

Study Start Date2018-11-16
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Anesthesia